shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > World News > Article > COVID 19 may last long despite vaccine rollout

‘COVID-19 may last long despite vaccine rollout’

Updated on: 14 February,2021 08:04 AM IST  |  Stockholm
Agencies |

With vaccine stockpiling in wealthier nations, head of EU illness management firm says, “it could be years before the virus is brought under control at a global level”

‘COVID-19 may last long despite vaccine rollout’

People arrive to receive a dose of Chinese-made Sinopharm COVID-19 vaccine in Serbia. Pic/AFP

The head of the EU’s illness management company warned on Friday that the novel Coronavirus could last indefinitely even as global infections slowed by nearly half in the last month and vaccine rollouts gathered pace in parts of the world.


In an interview, ECDC chief Andrea Ammon urged European nations particularly to not drop their guard in opposition to a virus that “seems very well adapted to humans” and will require consultants to tweak vaccines over time, as is the case with the seasonal flu.


“So we should be prepared that it will remain with us,” said Ammon, head of the Stockholm-based European Centre for Disease Prevention and Control. 


After the recent harsh wave of a pandemic that began in China more than 12 months ago, glimmers of hope flickered as recent data confirmed the speed of recent COVID-19 infections has slowed by 44.5  per cent worldwide over the previous month.

But illness consultants warned that vaccines will not finish the pandemic and that all nations should obtain doses in a quick and truthful method.

The European Medicines Agency has so far approved vaccines for the bloc developed by US-German firm Pfizer-BioNTech, US firm Moderna and British-Swedish firm AstraZeneca with Oxford University.

The EMA said on Friday it had started a “rolling review” of a vaccine from German manufacturer CureVac, the first step towards possible authorisation.

Pak approves China’s CanSino vaccine for emergency use
China’s CanSino COVID-19 vaccine has become the second Chinese vaccine to be approved by the Drug Regulatory Authority of Pakistan on Friday, Special Assistant to the Pakistani Prime Minister on Health Faisal Sultan said. Earlier in January, Pakistan approved China’s Sinopharm vaccine for emergency use after evaluating its safety and quality. Pakistan officially launched its vaccination drive on February 3.

CDC’s roadmap for reopening schools
The US Centers for Disease Control and Prevention recommends that schools adopt “essential elements”, including wearing masks, physical distancing and monitoring the level of spread in the community. It also calls for schools to implement a testing programme.

10,88,08,348
TOTAL Number OF CORONAVIRUS 

CASES IN THE WORLD

23,95,915
Number OF DEATHS WORLDWIDE 

8,08,37,108
Number OF RECOVERED PATIENTS

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK